Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

突变型p53诱导高尔基体小管囊泡化,驱动促转移分泌组。

阅读:4
作者:Valeria Capaci ,Lorenzo Bascetta # ,Marco Fantuz # ,Galina V Beznoussenko ,Roberta Sommaggio ,Valeria Cancila ,Andrea Bisso ,Elena Campaner ,Alexander A Mironov ,Jacek R Wiśniewski ,Luisa Ulloa Severino ,Denis Scaini ,Fleur Bossi ,Jodi Lees ,Noa Alon ,Ledia Brunga ,David Malkin ,Silvano Piazza ,Licio Collavin ,Antonio Rosato ,Silvio Bicciato ,Claudio Tripodo ,Fiamma Mantovani ,Giannino Del Sal

Abstract

TP53 missense mutations leading to the expression of mutant p53 oncoproteins are frequent driver events during tumorigenesis. p53 mutants promote tumor growth, metastasis and chemoresistance by affecting fundamental cellular pathways and functions. Here, we demonstrate that p53 mutants modify structure and function of the Golgi apparatus, culminating in the increased release of a pro-malignant secretome by tumor cells and primary fibroblasts from patients with Li-Fraumeni cancer predisposition syndrome. Mechanistically, interacting with the hypoxia responsive factor HIF1α, mutant p53 induces the expression of miR-30d, which in turn causes tubulo-vesiculation of the Golgi apparatus, leading to enhanced vesicular trafficking and secretion. The mut-p53/HIF1α/miR-30d axis potentiates the release of soluble factors and the deposition and remodeling of the ECM, affecting mechano-signaling and stromal cells activation within the tumor microenvironment, thereby enhancing tumor growth and metastatic colonization.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。